p53 is a venture capital fund specializing in early-stage investments in the biotech and pharma sectors. They provide Series A funding, with investments ranging from $250,000 to $5 million. One of their portfolio companies is Calluna Pharma, demonstrating their commitment to advancing medical and pharmaceutical innovations.
